SCHEMBL2032908

SCHEMBL2032908

CN[C@@H](COCc1ccccc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.61
FOLH1 Q04609 1/20 0.59
MME P08473 1/20 0.55
PPARG P37231 1/20 0.52
SLC1A1 P43005 1/20 0.51
MMP9 P14780 1/20 0.50
MMP14 P50281 1/20 0.50
CTSS P25774 1/20 0.48
CA1 P00915 4/20 0.47
CA2 P00918 2/20 0.47
CA7 P43166 2/20 0.47
CA9 Q16790 2/20 0.47
TSHR P16473 1/20 0.45
MMP1 P03956 1/20 0.45
MMP3 P08254 1/20 0.45
ALDH1A1 P00352 1/20 0.44
HTT P42858 1/20 0.44
ACE P12821 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17817736 1.00 PPARA (0.61) PPARAFOLH1MMEPPARGSLC1A1
SCHEMBL18630211 1.00 PPARA (0.61) PPARAFOLH1MMEPPARGSLC1A1
Hydrochloric Acid SCHEMBL22500531 0.98 PPARA (0.60) PPARAFOLH1MMEPPARGSLC1A1
SCHEMBL13844843 0.89 PPARA (0.53) PPARAFOLH1MMEPPARGSLC1A1
SCHEMBL20804457 0.89 PPARA (0.53) PPARAFOLH1MMEPPARGSLC1A1
SCHEMBL13227780 0.89 PPARA (0.53) PPARAFOLH1MMEPPARGSLC1A1
SCHEMBL1414148 0.89 PPARA (0.53) PPARAFOLH1MMEPPARGSLC1A1
SCHEMBL13013213 0.89 PPARA (0.53) PPARAFOLH1MMEPPARGSLC1A1
SCHEMBL13710930 0.87 PPARA (0.52) PPARAFOLH1MMEPPARGSLC1A1
Hydrochloric Acid SCHEMBL31612159 0.87 PPARA (0.52) PPARAFOLH1MMEPPARGSLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12565518-B2 Hybrid cyclic libraries and screens thereof THE JOHNS HOPKINS UNIVERSITY (US) 2026-03-03 US disclosed
US-20240262867-A1 HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF THE JOHNS HOPKINS UNIVERSITY 2024-08-08 US disclosed
US-12049521-B2 Hybrid cyclic libraries and screens thereof THE JOHNS HOPKINS UNIVERSITY (US) 2024-07-30 US disclosed
CN-118256591-A Cyclic peptide compound having high membrane permeability and library comprising same 中外制药株式会社 2024-06-28 CN disclosed
CN-110869544-B Cyclic peptide compound having high membrane permeability and library comprising same 中外制药株式会社 2024-03-08 CN disclosed
EP-4308575-A1 MACROCYCLES AS CFTR MODULATORS Idorsia Pharmaceuticals Ltd (CH) 2024-01-24 EP disclosed
US-20230278996-A1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS MOLECURE S.A. (PL) 2023-09-07 US disclosed
CN-115515937-A Dimers for the synthesis of peptidomimetics 范因斯坦医学研究院 2022-12-23 CN disclosed
WO-2022194399-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2022-09-22 WO disclosed
EP-3287458-B1 HYBRID CYCLIC LIBRARIES AND SCREENING THEREOF UNIV JOHNS HOPKINS (US) 2022-07-13 EP disclosed
EP-2061886-B1 Small cationic immunomodulatory peptides UNIV BRITISH COLUMBIA (CA) 2014-05-07 EP disclosed
US-20140073581-A1 Hybrid Cyclic Libraries and Screens Thereof THE JOHNS HOPKINS UNIVERSITY 2014-03-13 US disclosed
US-20130266597-A1 Small Cationic Antimicrobial Peptides THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-10-10 US disclosed
EP-2646440-A2 HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF The Johns Hopkins University (US) 2013-10-09 EP disclosed
US-8343475-B2 Small cationic antimicrobial peptides THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-01-01 US disclosed
WO-2012075048-A2 HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF THE JOHNS HOPKINS UNIVERSITY (US) 2012-06-07 WO disclosed
US-20110236429-A1 Small Cationic Antimicrobial Peptides THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2011-09-29 US disclosed
US-20110150917-A1 Small Cationic Antimicrobial Peptides THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2011-06-23 US disclosed
EP-2061886-A1 SMALL CATIONIC ANTIMICROBIAL PEPTIDES The University of British Columbia (CA) 2009-05-27 EP disclosed
WO-2008022444-A1 SMALL CATIONIC ANTIMICROBIAL PEPTIDES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565518-B2 Hybrid cyclic libraries and screens thereof NOLC1, BCL6, CHP1 PPARA 4500/4885FOLH1 3923/4885MME 3805/4885
US-20140073581-A1 Hybrid Cyclic Libraries and Screens Thereof CACYBP, HSPBP1, PEBP1 PPARA 4333/4885FOLH1 2167/4885MME 2656/4885
US-20230278996-A1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS CHI3L1, CHI3L2, CHIA PPARA 4708/4885FOLH1 1966/4885MME 392/4885
US-12049521-B2 Hybrid cyclic libraries and screens thereof CACYBP, HSPBP1, PEBP1 PPARA 4333/4885FOLH1 2167/4885MME 2656/4885
US-20240262867-A1 HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF CACYBP, HSPBP1, PEBP1 PPARA 4333/4885FOLH1 2167/4885MME 2656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.